Nanosonics Ltd. (NNCSF)
2.30
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 697.70M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -2.13% |
| Valuation | |
| PE Ratio | 58.82 |
| PE Ratio (Forward) | |
| PS Ratio | 5.144 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 72.61% |
Profile
| Nanosonics Ltd. engages in the provision of research, development, and commercialization of infection control and decontamination products and related technologies. It operates through the following geographical segments: North America, Europe and Middle East, and Asia Pacific. Its products include trophon EPR, trophon technology, and trophon2. The company was founded by Maurie Stang on November 14, 2000 and is headquartered in Sydney, Australia. |
| URL | http://www.nanosonics.com.au |
| Investor Relations URL | N/A |
| HQ State/Province | New South Wales (NSW) |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap Growth |
| Next Earnings Release | N/A |
| Last Earnings Release | Aug. 25, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Nanosonics Ltd. engages in the provision of research, development, and commercialization of infection control and decontamination products and related technologies. It operates through the following geographical segments: North America, Europe and Middle East, and Asia Pacific. Its products include trophon EPR, trophon technology, and trophon2. The company was founded by Maurie Stang on November 14, 2000 and is headquartered in Sydney, Australia. |
| URL | http://www.nanosonics.com.au |
| Investor Relations URL | N/A |
| HQ State/Province | New South Wales (NSW) |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap Growth |
| Next Earnings Release | N/A |
| Last Earnings Release | Aug. 25, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |